Literature DB >> 2575078

Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells.

R D Huby1, G Janossy, I A Lampert.   

Abstract

Cyclosporin A (CsA) is known to cause atrophy of the thymic medulla in normal mice. We show that medullary regeneration in lethally irradiated animals reconstituted with syngeneic marrow is also inhibited. For such animals, thymic cortical development is apparently normal. However, if the marrow is depleted of either Thy-1+ or Lyt-1+ cells, thymic regeneration is severely inhibited by CsA. This is not a permanent process, since thymic regeneration proceeds normally if the drug is withdrawn. CsA is only effective at preventing thymic regeneration if it is given at the time of grafting; after a delay of 3 days it is ineffective. We conclude that CsA inhibits the development of prothymocytes (pre-T cells) from common stem cells in the marrow. The significance of these findings with reference to T-cell ontogeny and clinical bone marrow (BM) transplantation is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575078      PMCID: PMC1385547     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

Review 1.  Cyclosporin in bone marrow transplantation.

Authors:  K Atkinson
Journal:  Bone Marrow Transplant       Date:  1987-02       Impact factor: 5.483

2.  Deletion of self-reactive thymocytes occurs at a CD4+8+ precursor stage.

Authors:  B J Fowlkes; R H Schwartz; D M Pardoll
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

3.  Cyclosporin-resistant and -sensitive T-lymphocyte subsets.

Authors:  A D Hess; P N Colombani
Journal:  Ann Inst Pasteur Immunol       Date:  1987 Jul-Aug

4.  Mechanism of cyclosporin action: in vitro studies.

Authors:  B Ryffel
Journal:  Ann Inst Pasteur Immunol       Date:  1987 Jul-Aug

5.  Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.

Authors:  D T Harris; W J Kozumbo; P A Cerutti; J C Cerottini
Journal:  Cell Immunol       Date:  1987-10-01       Impact factor: 4.868

6.  Transient expression of IL-2 receptor precedes the differentiation of immature thymocytes.

Authors:  R P Shimonkevitz; L A Husmann; M J Bevan; I N Crispe
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

7.  Importance of IL-2 receptors in intra-thymic generation of cells expressing T-cell receptors.

Authors:  E J Jenkinson; R Kingston; J J Owen
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

8.  Syngeneic graft-versus-host disease induced by cyclosporine--a reappraisal.

Authors:  L H Chow; L Mosbach-Ozmen; B Ryffel; J F Borel
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

9.  Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemia.

Authors:  G Papa; W Arcese; F R Mauro; A Bianchi; G Alimena; L De Felice; G Isacchi; D Pasqualetti; F Malagnino; M Purpura
Journal:  Leuk Res       Date:  1986       Impact factor: 3.156

10.  The cyclosporins inhibit lymphocyte activation at more than one site.

Authors:  E W Gelfand; R K Cheung; G B Mills
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.